Discovery of 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole, a Novel in Vivo Cannabinoid Antagonist Containing a 1,2,4-Triazole Motif-Reference-Cited by-同舟云学术

Discovery of 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole, a Novel in Vivo Cannabinoid Antagonist Containing a 1,2,4-Triazole Motif

Published:2004-04-06 Issue:11 Volume:47 Page:2939-2942
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Jagerovic Nadine¹,Hernandez-Folgado Laura¹,Alkorta Ibon¹,Goya Pilar¹,Navarro Miguel¹,Serrano Antonia¹,Rodriguez de Fonseca Fernando¹,Dannert M. Teresa¹,Alsasua Angela¹,Suardiaz Margarita¹,Pascual David¹,Martín Maria Isabel¹

Affiliation:

1. Instituto de Química Médica, Consejo Superior de Investigaciones Científicas, Juan de la Cierva, 3, E-28006 Madrid, Spain, Departamento de Psicobiología, Facultad de Psicología, Universidad Complutense de Madrid, E-28040 Madrid, Spain, Fundación Hospital Carlos Haya, E-29010 Málaga, Spain, Facultad de Medicina, Universidad Complutense de Madrid, E-28040 Madrid, Spain, and Unidad de Farmacología, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avda. Atenas, s/n, E-28922 Alcorcón, Madrid, Spain

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm031099y

Reference22 articles.

1. Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

2. Cannabinergic ligands

3. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes

4. Recent advances in cannabinoid receptor agonists and antagonists

5. From cannabis to cannabinergics

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, relative configuration and CB1 receptor affinity studies for a set of 1,2,3-triazole derivatives;Journal of Molecular Structure;2023-06

2. Oxazole and isoxazole: From one-pot synthesis to medical applications;Tetrahedron;2022-07

3. 1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists;Arabian Journal of Chemistry;2022-01

4. Peripheral CB1R as a modulator of metabolic inflammation;The FASEB Journal;2021-03-14

5. Alkali Salt-Catalyzed Aza-Michael Addition of 1,2,4-Triazole to α,β-Unsaturated Ketones and Imides;Chinese Journal of Organic Chemistry;2020